The blood–brain barrier (BBB) is a highly selective semipermeable border of endothelial cells that prevents solutes in the circulating blood from non-selectively crossing into the extracellular fluid of the central nervous system where neurons reside.
Drug design and discovery is a very expensive process, with numerous new compounds being developed at a rapid rate. Only around 2% of known drugs can pass through the BBB, this presents a problem in the Central Nervous System (CNS) drug development.
This project aims to develop a solution that can predict, with confidence, the probability of a drug passing through the BBB in the hope that this can speed up the process of developing a CNS drug.
This project is still active more work in being going this project, addtional propertie of drug and protein on the membrane is also considered in future update.
- Martins e.tal
- Gupta etal
- William A Banks[doi:10.1186/1471-2377-9-S1-S3]